4-chloro-5-fluoro-2-iodophenol 、 1-Boc-吡唑-4-硼酸频哪醇酯 以gave the title compound as a white solid (200 mg, 38%)的产率得到tert-butyl 4-(5-chloro-4-fluoro-2-hydroxyphenyl)-1H-pyrazole-1-carboxylate
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts, solvates or tautomers therof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
The present invention relates to compounds of the formula
and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
The present invention relates to compounds of the formula
and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.